We are live on
!
Find out more
TCM
TCG Crossover Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
1,165.83%
This Fund
S&P 500
This Quarter
Est. Return
+83.13%
1 Year Est. Return
+1,165.83%
3 Year Est. Return
+3,168.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$567M
AUM Growth
+$233M
(+70%)
Cap. Flow
+$110M
Cap. Flow
% of AUM
19.49%
Top 10 Holdings %
Top 10 Hldgs %
79.55%
Holding
26
New
5
Increased
7
Reduced
4
Closed
5
Top Buys
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$27M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$25.2M |
| 3 |
VTYX
Ventyx Biosciences
VTYX
|
+$23.3M |
| 4 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
+$18.8M |
| 5 |
KALV
KalVista Pharmaceuticals
KALV
|
+$18.2M |
Top Sells
| 1 |
ALLK
Allakos
ALLK
|
+$10.1M |
| 2 |
AKUS
Akouos Inc
AKUS
|
+$9.13M |
| 3 |
Tango Therapeutics
TNGX
|
+$4.24M |
| 4 |
Viridian Therapeutics
VRDN
|
+$4.16M |
| 5 |
Dianthus Therapeutics
DNTH
|
+$3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $110M | 19.43% |
5,141,118
+1,263,215
| +33% | +$27M |
|
|
2
Madrigal Pharmaceuticals
MDGL
$12.5B
| $83.6M | 14.76% |
288,054
+258,054
| +860% | +$25.2M |
|
3
Cogent Biosciences
COGT
$6.59B
| $42M | 7.41% |
3,631,042
+150,000
| +4% | +$1.86M |
|
|
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
| $37M | 6.53% |
5,905,400
| – | – |
|
5
Geron
GERN
$911M
| $36.8M | 6.49% |
15,187,073
+3,071,147
| +25% | +$6.88M |
|
|
SLN
6
Silence Therapeutics
SLN
$492M
| $32.1M | 5.67% |
2,104,875
| – | – |
|
|
JBIO
7
Jade Biosciences
JBIO
$1.29B
| $31.7M | 5.59% |
30,894
+3,478
| +13% | +$2.53M |
|
|
8
Viridian Therapeutics
VRDN
$2B
| $28.7M | 5.07% |
983,610
-180,390
| -15% | -$4.16M |
|
|
VTYX
9
DELISTED
Ventyx Biosciences
VTYX
| $25.8M | 4.56% |
+787,231
| New | +$23.3M |
|
|
KALV
10
DELISTED
KalVista Pharmaceuticals
KALV
| $23M | 4.05% |
+3,395,495
| New | +$18.2M |
|
|
VECT
11
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $20.2M | 3.57% |
+2,333,300
| New | +$18.8M |
|
12
Aclaris Therapeutics
ACRS
$764M
| $18M | 3.18% |
1,144,939
| – | – |
|
13
Kura Oncology
KURA
$970M
| $17.7M | 3.12% |
1,423,642
+75,000
| +6% | +$1.09M |
|
14
Immunovant
IMVT
$8.05B
| $15.2M | 2.68% |
+854,853
| New | +$10.8M |
|
15
Tyra Biosciences
TYRA
$1.89B
| $15.1M | 2.67% |
1,989,103
+1,043,396
| +110% | +$7.38M |
|
16
MoonLake Immunotherapeutics
MLTX
$1.62B
| $10.5M | 1.85% |
1,000,000
| – | – |
|
17
Entrada Therapeutics
TRDA
$271M
| $7.91M | 1.4% |
584,955
-57,234
| -9% | -$1M |
|
|
MRUS
18
DELISTED
Merus
MRUS
| $4.64M | 0.82% |
300,000
| – | – |
|
19
Cabaletta Bio
CABA
$427M
| $4.5M | 0.79% |
+486,795
| New | +$1.77M |
|
|
ALPN
20
DELISTED
Alpine Immune Sciences Inc
ALPN
| $1.86M | 0.33% |
253,069
-1,500
| -0.6% | -$9.59K |
|
|
ELEV
21
DELISTED
Elevation Oncology
ELEV
| $274K | 0.05% |
288,390
-266,610
| -48% | -$271K |
|
|
ALLK
22
DELISTED
Allakos
ALLK
| – | – |
-1,643,500
| Closed | -$10.1M |
|
|
23
Dianthus Therapeutics
DNTH
$5.33B
| – | – |
-132,758
| Closed | -$3M |
|
|
24
Tango Therapeutics
TNGX
$4.73B
| – | – |
-1,172,250
| Closed | -$4.24M |
|
25
Zai Lab
ZLAB
$2.34B
| – | – |
-72,777
| Closed | -$2.49M |
|
Similar funds
DILIC
IIM
ACM
BCP
AL
ACA
MSC
TH